top of page |
Type and details of transgene |
Is the transgene Plasmodium derived |
Transgene: not Plasmodium |
Transgene name | GFP(gfp-mut3) fused to the HT-motif of the P. falciparum HRPII gene |
top of page |
Details of the genetic modification |
Inducable system used | No |
Additional remarks inducable system |
|
Type of plasmid/construct | Plasmid single cross-over |
PlasmoGEM (Sanger) construct/vector used | No |
Modified PlasmoGEM construct/vector used | No
|
Plasmid/construct map |
|
Plasmid/construct sequence |
|
Restriction sites to linearize plasmid |
|
Selectable marker used to select the mutant parasite | tgdhfr |
Promoter of the selectable marker | pbdhfr |
Selection (positive) procedure | pyrimethamine |
Selection (negative) procedure | No |
Additional remarks genetic modification | A previously described plasmid (pPbGFPCON or pL0016; www.mr4.org) was used for cloning of HRPIIminhis.HT.GFP (a truncated HRPII gene containing a minimal histidine sequence, host-targeting motif, and GFP tag) and HRPIIminhis.Δ.GFP (a truncated HRPII gene containing a minimal histidine sequence, an 11 amino acid alanine-rich replacement of the host-targeting motif, and GFP tag)(Lopez-Estrano C. et al (2003) Proc Natl Acad Sci U S A 100: 12402-12407). pL0016 contains a GFP expression cassette and the Toxoplasma gondii dihydrofolate reductase selectable marker (tgdhfr) for drug selection with perimethamine. HRPIIminhis.HT.GFP and HRPIIminhis.Δ.GFP was amplified from pBacII(HT-GFPmembmyc) and pBacII(Δ-GFPmembmyc), respectively, using the following primers: 5′ - ATAT GGATCC ATG GTT TCC TTC TCA AAA AAT AAA GTA TTA TCC – 3′ and 5′ - GGC CGG ATC CCT ATT TGT ATA GTT CAT CCA TGC CAT GTG TAA TCC C – 3′. pL0016 was digested with BamHI to remove GFP. PCR products for HRPIIminhis.WT.GFP and HRPIIminhis.Δ.GFP were digested with BamHI and ligated with pL0016. pL0016 (HTsol-GFP) and pL0016 (Δsol-GFP) were digested with ApaI and SacII.
The plasmid integrates into the c/d-type rrna gene unit by single cross-over integration (and not by double cross-over integration as mentioned in the paper!; see also RMgm5 for a mutant that is generated using pl0016 and expresses GFP). |
Additional remarks selection procedure | |
top of page |
Other details transgene |
top of page |
Promoter |
Gene Model of Parasite |
PBANKA_1133300
|
Gene Model P. falciparum ortholog |
PF3D7_1357100
|
Gene product | elongation factor 1-alpha |
Gene product: Alternative name | eef1a |
Primer information details of the primers used for amplification of the promoter sequence
Primer information details of the primers used for amplification of the promoter sequence
Sequence Primer 1 | |
Additional information primer 1 | |
Sequence Primer 2 | |
Additional information primer 2 | |
|
|
top of page |
3'-UTR |
Gene Model of Parasite |
PBANKA_0719300
|
Gene product | bifunctional dihydrofolate reductase-thymidylate synthase, putative |
Gene product: Alternative name | dhfr/ts |
Primer information details of the primers used for amplification the 3'-UTR sequences
Primer information details of the primers used for amplification the 3'-UTR sequences
Sequence Primer 1 | |
Additional information primer 1 | |
Sequence Primer 2 | |
Additional information primer 2 | |
|
|
Insertion/Replacement locus |
Replacement / Insertion | Insertion locus |
Gene Model of Parasite |
Not available
|
Gene product | Not available |
Gene product: Alternative name | small subunit ribosomal rna gene (c/d-type unit) |
Primer information details of the primers used for amplification of the target sequences
Primer information details of the primers used for amplification of the target sequences
Sequence Primer 1 | |
Additional information primer 1 | |
Sequence Primer 2 | |
Additional information primer 2 | |
Sequence Primer 3 | |
Additional information primer 3 | |
Sequence Primer 4 | |
Additional information primer 4 | |
|
|
top of page |